1. Home
  2. RLAY vs MATW Comparison

RLAY vs MATW Comparison

Compare RLAY & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • MATW
  • Stock Information
  • Founded
  • RLAY 2015
  • MATW 1850
  • Country
  • RLAY United States
  • MATW United States
  • Employees
  • RLAY N/A
  • MATW N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • MATW Metal Fabrications
  • Sector
  • RLAY Health Care
  • MATW Telecommunications
  • Exchange
  • RLAY Nasdaq
  • MATW Nasdaq
  • Market Cap
  • RLAY 576.1M
  • MATW 654.6M
  • IPO Year
  • RLAY 2020
  • MATW 1994
  • Fundamental
  • Price
  • RLAY $3.63
  • MATW $25.44
  • Analyst Decision
  • RLAY Strong Buy
  • MATW Strong Buy
  • Analyst Count
  • RLAY 11
  • MATW 1
  • Target Price
  • RLAY $18.40
  • MATW $40.00
  • AVG Volume (30 Days)
  • RLAY 1.6M
  • MATW 220.4K
  • Earning Date
  • RLAY 08-05-2025
  • MATW 07-31-2025
  • Dividend Yield
  • RLAY N/A
  • MATW 3.93%
  • EPS Growth
  • RLAY N/A
  • MATW N/A
  • EPS
  • RLAY N/A
  • MATW N/A
  • Revenue
  • RLAY $7,679,000.00
  • MATW $1,703,999,000.00
  • Revenue This Year
  • RLAY $14.31
  • MATW N/A
  • Revenue Next Year
  • RLAY N/A
  • MATW N/A
  • P/E Ratio
  • RLAY N/A
  • MATW N/A
  • Revenue Growth
  • RLAY N/A
  • MATW N/A
  • 52 Week Low
  • RLAY $1.78
  • MATW $18.50
  • 52 Week High
  • RLAY $10.72
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 63.22
  • MATW 70.74
  • Support Level
  • RLAY $3.10
  • MATW $23.52
  • Resistance Level
  • RLAY $3.75
  • MATW $24.59
  • Average True Range (ATR)
  • RLAY 0.23
  • MATW 0.90
  • MACD
  • RLAY 0.03
  • MATW 0.36
  • Stochastic Oscillator
  • RLAY 84.42
  • MATW 91.98

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: